Engineering transcriptional regulation for cell-based therapies.

MLA

Recktenwald, Matthias, et al. “Engineering Transcriptional Regulation for Cell-Based Therapies.” SLAS Technology, vol. 29, no. 2, Apr. 2024, p. 100121. EBSCOhost, https://doi.org/10.1016/j.slast.2024.100121.

APA

Recktenwald, M., Hutt, E., Davis, L., MacAulay, J., Daringer, N. M., Galie, P. A., Staehle, M. M., & Vega, S. L. (2024). Engineering transcriptional regulation for cell-based therapies. SLAS Technology, 29(2), 100121. https://doi.org/10.1016/j.slast.2024.100121

Chicago

Recktenwald, Matthias, Evan Hutt, Leah Davis, James MacAulay, Nichole M Daringer, Peter A Galie, Mary M Staehle, and Sebastián L Vega. 2024. “Engineering Transcriptional Regulation for Cell-Based Therapies.” SLAS Technology 29 (2): 100121. doi:10.1016/j.slast.2024.100121.